Sandbox:Mitra3
{{familytree | | | C01 | | | C02 | | | C03 | | C04 | | C05 | | C06 | | |
|C01= •Thrmobolytics
•Percutaneous coronary intervention (PCI)
|C02=
•Percutaneous coronary intervention (PCI)
|C02=
• Avoidance of preload reducing agents, such as:
- ❑Nitrates
- ❑Diuretics
- ❑Morphin
• In patients with hypotension (without pulmonary congestion):
- ❑ Intravenous administration of Fluids (N/S 0.9% at 40mL for 2L, to maintain CVP <15mmHg and PCWP between 18-24 mmHg)
• Systemic or pulmonary vasodilators:
- ❑Nitrosrusside
- ❑Inhaled nitric oxide<be>
• In patients with bradyarrhthmias:
- ❑Atropine
- ❑Pacemaker
• In patients with atrioventricular block:
- ❑Temporary dual-chamber pacemaker
In patients with refractory hypotension:
- ❑Dobutamine (along with fluids)
- ❑Other inotropes:
- milrinone
- norepinephrine
• May be needed in patients with cardiogenic shock secondary to RVMI:
- ❑Direct RV support
- ❑Indirect RV support
- ❑Biventricular support||
Therapuetic Considerations in RVMI | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reperfusion | Maintenance of RV preload | Decreased RV afterload | Restoring Rate/Rhythm and AV synchrony | Inotropic support | Mechanical Circulatory Support | ||||||||||||||||||||||||||||||||||||||||||||||||||||||